ClearBridge Advisors »

Sarepta Therapeutics shares owned by ClearBridge Advisors

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by ClearBridge Advisors from 13F filings

Historical chart of ClearBridge Advisors investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by ClearBridge Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by ClearBridge Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 151k 96.43

More positions owned by ClearBridge Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
UnitedHealth (UNH)
Amazon (AMZN)
Visa Com Cl A (V)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Comcast Corp Cl A (CMCSA)
JPMorgan Chase & Co. (JPM)
Netflix (NFLX)
Thermo Fisher Scientific (TMO)
Adobe Systems Incorporated (ADBE)
Vertex Pharmaceuticals Incorporated (VRTX)
Union Pacific Corporation (UNP)

View all positions for ClearBridge Advisors

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics